Advertisement
Advertisement
XGN
Exagen Inc. Common Stock
3.80
USDSponsored
-0.10
-2.56%
Nov 19, 15:59 UTC -5
Closed
After-Market
3.81
+0.01
+0.13%
Exagen Inc. Common Stock (XGN) Earnings
XGN Earnings Reports
Positive Surprise Ratio
XGN beat 22 of 29 last estimates.
76%
Next Report
Date of Next Report
Mar 08, 2027
Estimate for Q4 26 (Revenue/ EPS)
$18.25M
/-$0.18
Implied change from Q3 26 (Revenue/ EPS)
-0.90%
/-28.00%
Implied change from Q4 25 (Revenue/ EPS)
+9.75%
/-10.00%
Exagen Inc. Common Stock earnings per share and revenue
On Nov 10, 2026, XGN reported earnings of -0.25 USD per share (EPS) for Q3 26, missing the estimate of -0.18 USD, resulting in a -35.35% surprise. Revenue reached 18.42 million, compared to an expected 18.53 million, with a -0.59% difference. The market reacted with a -25.92% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.18 USD, with revenue projected to reach 18.25 million USD, implying an decrease of -28.00% EPS, and decrease of -0.90% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
What were Exagen Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Exagen Inc. Common Stock reported EPS of -$0.25, missing estimates by -35.35%, and revenue of $18.42M, -0.59% below expectations.
How did the market react to Exagen Inc. Common Stock's Q3 2026 earnings?
The stock price moved down -25.92%, changed from $7.10 before the earnings release to $5.26 the day after.
When is Exagen Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 08, 2027.
What are the forecasts for Exagen Inc. Common Stock's next earnings report?
Based on --
analysts, Exagen Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $18.25M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.